Tyrx presents early clinical results from AIGISRXTM antibacterial envelope retrospective registry

News | 05. 14. 2009


TYRX, Inc., a leader in the commercialization of implantable medical-pharmaceutical devices announced today at the 30th Annual Scientific Sessions of the Heart Rhythm Society the initial, interim clinical results from its AIGISRXTM Antibacterial Envelope Retrospective Registry.